Main Surgery – 01829 732401
(all calls are recorded)
Option 1 – Reception
Option 2 – Secretary

Email the surgery

Covid Vaccinations Given Overseas

Overseas Vaccine Record Validation Service

From 10th February 2022, changes will be made to the National Booking Service (NBS) to allow those aged 16 years and above to book and attend in person, an appointment to have their identity verified and vaccine records from overseas validated.

Those aged between 16 and 17 years of age will not be required to have a parent, carer, or guardian attend the appointment with them.

The current eligibility criteria to have overseas vaccine records validated has been set by the Department of Health and Social Care (DHSC) as listed below.

Individuals to:

  • have received one of the currently recognised Medicines and Healthcare Products Regulatory Agency (MHRA) approved vaccine types for use in England: AstraZeneca (Vaxzevria) / Pfizer/BioNTech (Comirnaty) / Johnson & Johnson (Janssen) /  Moderna (Spikevax) or Novavax (Nuvaxovid)
  • be registered with a GP in England. Individuals can register with a GP if they do not have one
  • be able to attend the face-to-face appointment with photographic ID (Passport or UK Driving Licence) and evidence of overseas vaccination records.

Evidence Validation and Administration of Vaccines

A change in the vaccine types accepted by the service is imminent. We are awaiting guidance from the UK Health Security Agency (UKHSA) and Public Health England (PHE) and will update sites as soon as the new guidance is published.

Appointment Duration

Following feedback from sites, as part of the changes being deployed today (10th February 2022), QFlow appointment duration is being reduced from 15 minutes to 10 minutes.

Under16’s

This group are currently eligible for vaccination in line with the latest guidance. Work is underway to enable eligible under 16’s to have their overseas vaccine records validated through a parent/guardian attending the appointment on the child’s behalf.  A further update will be shared when a deployment date is confirmed.